molecular remissions

Related by string. * MOLECULAR . Molecular : molecular diagnostic assays . molecular biology . molecular mechanisms underlying . underlying molecular mechanisms . Molecular Targets . Molecular Biology . molecular / Remissions . Remission : endoscopic remission . spontaneous remission . remission Bobbit . induce remission . DAS# remission . complete remissions . remission induction * *

Related by context. Frequent words. (Click for all words.) 63 complete remissions 61 heavily pretreated 60 complete cytogenetic 60 tumor regression 59 systemic toxicity 58 dasatinib 58 superficial bladder cancer 58 mg kg dose 58 Azedra 58 interferon therapy 58 peripheral blood mononuclear 58 androgen deprivation 57 chlorambucil 57 Traficet EN 57 mRCC 57 antibody titers 57 xenograft 57 HER2/neu 57 cytogenetic response 57 neutralizing antibody 57 decitabine 57 OncoVEX GM CSF 57 humanized antibody 57 HGS ETR1 57 surrogate endpoint 56 GvHD 56 haematological 56 hematologic 56 virologic 56 lytic 56 tumor lysis syndrome 56 virologic failure 56 dose limiting toxicities 56 orally bioavailable 56 tipranavir 56 RRMS patients 56 antibody responses 56 tumor shrinkage 56 Natalizumab 56 nilotinib 56 CMV infection 55 nab paclitaxel 55 evaluable 55 patients evaluable 55 DAVANAT 55 therapeutic regimens 55 sustained virologic response 55 lymphopenia 55 MAb 55 antitumor 55 CCX# 55 ponatinib 55 RECIST criteria 55 indolent NHL 55 inhibitory effects 55 cytotoxicity 55 fulvestrant 55 hypercalcemia 55 serum concentrations 55 seroprotection 54 interferon alfa 54 DOXIL 54 leukemic 54 Combination therapy 54 chronic HCV 54 mycophenolate mofetil 54 GEMZAR 54 bleomycin 54 biodistribution 54 xenograft models 54 chemoradiotherapy 54 allogeneic stem cell 54 immunomodulator 54 febrile neutropenia 54 amphotericin B 54 HSCT 54 neoadjuvant chemotherapy 54 FLT3 54 FOLFOX 54 HER-2/neu 54 epirubicin 54 adjuvant therapy 54 TREANDA 54 viremia 54 IgM 54 null responders 54 myeloproliferative disorders 54 virologic response 54 C1 INH 54 IgG antibodies 54 partial agonist 54 Erlotinib 54 IFN gamma 54 HER2 negative 54 Phase 2a trial 54 interferon beta 54 CoFactor 54 dose cohorts 54 neoadjuvant 54 grade gliomas 53 pertuzumab

Back to home page